| pubmed-article:15510896 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15510896 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:15510896 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15510896 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
| pubmed-article:15510896 | lifeskim:mentions | umls-concept:C0019167 | lld:lifeskim |
| pubmed-article:15510896 | lifeskim:mentions | umls-concept:C0209738 | lld:lifeskim |
| pubmed-article:15510896 | lifeskim:mentions | umls-concept:C0524909 | lld:lifeskim |
| pubmed-article:15510896 | lifeskim:mentions | umls-concept:C0237284 | lld:lifeskim |
| pubmed-article:15510896 | lifeskim:mentions | umls-concept:C0205156 | lld:lifeskim |
| pubmed-article:15510896 | lifeskim:mentions | umls-concept:C0332282 | lld:lifeskim |
| pubmed-article:15510896 | pubmed:issue | 96 | lld:pubmed |
| pubmed-article:15510896 | pubmed:dateCreated | 2004-10-29 | lld:pubmed |
| pubmed-article:15510896 | pubmed:abstractText | The aim of the study was evaluation the HBeAg/antiHBe seroconversion frequency as a result of lamivudine treatment in children who are nonresponders to previous IFN-alpha therapy. | lld:pubmed |
| pubmed-article:15510896 | pubmed:language | pol | lld:pubmed |
| pubmed-article:15510896 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15510896 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15510896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15510896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15510896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15510896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15510896 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15510896 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15510896 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15510896 | pubmed:issn | 1426-9686 | lld:pubmed |
| pubmed-article:15510896 | pubmed:author | pubmed-author:KaczmarskiMac... | lld:pubmed |
| pubmed-article:15510896 | pubmed:author | pubmed-author:LebensztejnDa... | lld:pubmed |
| pubmed-article:15510896 | pubmed:author | pubmed-author:SkibaElzbieta... | lld:pubmed |
| pubmed-article:15510896 | pubmed:author | pubmed-author:Sobaniec-Loto... | lld:pubmed |
| pubmed-article:15510896 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15510896 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:15510896 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15510896 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15510896 | pubmed:pagination | 557-9 | lld:pubmed |
| pubmed-article:15510896 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:meshHeading | pubmed-meshheading:15510896... | lld:pubmed |
| pubmed-article:15510896 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15510896 | pubmed:articleTitle | [The HBeAg/antiHBe seroconversion as a result of lamivudine treatment in children with chronic hepatitis B unresponsive to previous interferon alpha therapy]. | lld:pubmed |
| pubmed-article:15510896 | pubmed:affiliation | III Klinika Chorób Dzieci AM w Bia?ymstoku. | lld:pubmed |
| pubmed-article:15510896 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15510896 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15510896 | pubmed:publicationType | English Abstract | lld:pubmed |
